Treatment of Neuropathic Pain with Venlafaxine: A Systematic Review
暂无分享,去创建一个
[1] V. Coelho,et al. Pathophysiology of the Constant Burning, Tingling Element of Neuropathic Pain: a New Hypothesis , 2014, Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery.
[2] R. Treede,et al. Neuropathic low back pain in clinical practice , 2016, European journal of pain.
[3] G. Alpak,et al. Efficacy of venlafaxine for the relief of taxane and oxaliplatin-induced acute neurotoxicity: a single-center retrospective case–control study , 2016, Supportive Care in Cancer.
[4] M. Henman,et al. Venlafaxine for neuropathic pain in adults. , 2015, The Cochrane database of systematic reviews.
[5] A. Heinemann,et al. Efficacy of venlafaxine XR for the treatment of pain in patients with spinal cord injury and major depression: a randomized, controlled trial. , 2015, Archives of physical medicine and rehabilitation.
[6] D. Afshari,et al. Evaluation of the efficacy and safety of pregabalin, venlafaxine, and carbamazepine in patients with painful diabetic peripheral neuropathy , 2014, Neurosciences.
[7] S. Rajbhandari,et al. Pathogenesis of Painful Diabetic Neuropathy , 2014, Pain research and treatment.
[8] R. Sansone,et al. STRESS AND TRAUMA: Psychotherapy and Pharmacotherapy for Depersonalization/Derealization Disorder. , 2014 .
[9] Steven P. Cohen,et al. Neuropathic pain: mechanisms and their clinical implications , 2014, BMJ : British Medical Journal.
[10] R. Sansone,et al. Serotonin norepinephrine reuptake inhibitors: a pharmacological comparison. , 2014, Innovations in clinical neuroscience.
[11] M. Swan,et al. Complex regional pain syndrome: practical diagnostic and treatment guidelines, 4th edition. , 2013, Pain medicine.
[12] E. Raymond,et al. Efficacy of venlafaxine for the prevention and relief of oxaliplatin-induced acute neurotoxicity: results of EFFOX, a randomized, double-blind, placebo-controlled phase III trial. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.
[13] C. Voscopoulos,et al. When does acute pain become chronic? , 2010, British journal of anaesthesia.
[14] T. Yaguchi,et al. Noradrenaline stimulates ATP release from DRG neurons by targeting β3 adrenoceptors as a factor of neuropathic pain , 2010, Journal of cellular physiology.
[15] Tammy J. Lindsay,et al. Treating diabetic peripheral neuropathic pain. , 2010, American family physician.
[16] Y. Amr,et al. Evaluation of Efficacy of the Perioperative Administration of Venlafaxine or Gabapentin on Acute and Chronic Postmastectomy Pain , 2010, The Clinical journal of pain.
[17] William Eardley,et al. An open-label, non-randomized comparison of venlafaxine and gabapentin as monotherapy or adjuvant therapy in the management of neuropathic pain in patients with peripheral neuropathy , 2010, Journal of pain research.
[18] R. Treede,et al. Recommendations for the Pharmacological Management of Neuropathic Pain: An Overview and Literature Update SUPPLEMENT ARTICLE , 2010 .
[19] W. Faber,et al. Pain, Pain, Go Away , 2009 .
[20] P. Christo,et al. Pharmacological and interventional treatments for neuropathic pain , 2009 .
[21] S. Waxman,et al. Multiple sodium channel isoforms and mitogen‐activated protein kinases are present in painful human neuromas , 2008, Annals of neurology.
[22] R. Sansone,et al. Pain, pain, go away: antidepressants and pain management. , 2008, Psychiatry (Edgmont (Pa. : Township)).
[23] S. Montgomery. Tolerability of Serotonin Norepinephrine Reuptake Inhibitor Antidepressants , 2008, CNS Spectrums.
[24] H. Kayabaşı,et al. The effect of venlafaxine HCl on painful peripheral diabetic neuropathy in patients with type 2 diabetes mellitus. , 2008, Journal of diabetes and its complications.
[25] Xiao Ying-guang. Venlafaxine Extended Release and Sertraline in the Treatment of Depression-control Study , 2007 .
[26] G. Wilkinson,et al. Seminars in general adult psychiatry , 2007 .
[27] Qifu Li,et al. Effects of Venlafaxine and Carbamazepine for Painful Peripheral Diabetic Neuropathy: A Randomized, Double-blind and Double- dummy, Controlled Multi-center Trial , 2006 .
[28] Ralf Baron,et al. Mechanisms of Disease: neuropathic pain—a clinical perspective , 2006, Nature Clinical Practice Neurology.
[29] L. Arendt-Nielsen,et al. The effect of venlafaxine on ongoing and experimentally induced pain in neuropathic pain patients: a double blind, placebo controlled study , 2005, European journal of pain.
[30] Olivier Poirot,et al. Silencing of the Cav3.2 T‐type calcium channel gene in sensory neurons demonstrates its major role in nociception , 2005, The EMBO journal.
[31] E. Kalso,et al. Venlafaxine in the treatment of atypical facial pain: a randomized controlled trial. , 2004, Journal of orofacial pain.
[32] T. Jensen,et al. Venlafaxine versus imipramine in painful polyneuropathy , 2003, Neurology.
[33] E. Kalso,et al. Venlafaxine in neuropathic pain following treatment of breast cancer , 2002, European journal of pain.
[34] Sulayman D. Dib-Hajj,et al. Nav1.3 Sodium Channels: Rapid Repriming and Slow Closed-State Inactivation Display Quantitative Differences after Expression in a Mammalian Cell Line and in Spinal Sensory Neurons , 2001, The Journal of Neuroscience.
[35] D. Moulin,et al. Treatment of Neuropathic Pain with Venlafaxine , 2001, The Annals of pharmacotherapy.
[36] R. Baron. Peripheral Neuropathic Pain: From Mechanisms to Symptoms , 2000, The Clinical journal of pain.
[37] S. Preskorn,et al. Evidence of the dual mechanisms of action of venlafaxine. , 2000, Archives of general psychiatry.
[38] D. Bouhassira,et al. Mechanisms of pain in peripheral neuropathy , 1999, Acta neurologica Scandinavica. Supplementum.
[39] M. Devor,et al. Membrane Potential Oscillations in Dorsal Root Ganglion Neurons: Role in Normal Electrogenesis and Neuropathic Pain , 1999, The Journal of Neuroscience.
[40] P. Franklin. Pain, pain, go away... , 1997, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.
[41] J. Levine,et al. Interactions of sympathetic and primary afferent neurons following nerve injury and tissue trauma. , 1996, Progress in brain research.
[42] P. Benfield,et al. Venlafaxine. A review of its pharmacology and therapeutic potential in depression. , 1995, Drugs.
[43] G. Bennett. The role of the sympathetic nervous system in painful peripheral neuropathy , 1991, PAIN.
[44] M. Zimmermann,et al. The bradykinin-induced release of substance P from nerve fibre endings in the rat saphenous nerve neuroma is not related to electrophysiological excitation , 1988, Neuroscience Letters.
[45] R. Hughes,et al. Peripheral neuropathy. , 1982, The New England journal of medicine.